Data / Research funding / Puerto Rico / Lifegene-Biomarks, Inc.
Lifegene-Biomarks, Inc.: 4 NIH awards ($6.1M), fiscal years 2021 to 2026
Lifegene-Biomarks, Inc. in San Juan, PR is funded under 4 NIH awards ($6.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- GGR9ABCTBGG5
- State
- Puerto Rico
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | NIH | National Cancer Institute | 2021 to 2023 | $2,399,998 | September 15, 2021 | May 31, 2025 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
| Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,732,492 | June 1, 2024 | May 31, 2027 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
| Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | NIH | National Cancer Institute | 2023 to 2025 | $1,205,344 | September 20, 2023 | May 31, 2027 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
| Precision methylation biomarkers linked to cancer disparities | NIH | National Institute on Minority Health and Health Disparities | 2021 | $733,762 | September 24, 2019 | May 31, 2022 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 2 | $2,369,583 | 0 | $0 |
| 2024 | 1 | $275,767 | 0 | $0 |
| 2023 | 2 | $1,292,486 | 0 | $0 |
| 2022 | 1 | $1,000,000 | 0 | $0 |
| 2021 | 2 | $1,133,760 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-27-001 | NIH | 93.394 | November 10, 2026 | $150,000 | Same assistance listing 93.394 as 2 awards here |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-27-002 | NIH | 93.394 | November 10, 2026 | $300,000 | Same assistance listing 93.394 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.307 | November 18, 2026 | Not listed | Same assistance listing 93.307 as 2 awards here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.394 | November 20, 2026 | Not listed | Same assistance listing 93.394 as 2 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.307 | November 24, 2026 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | RFA-OD-27-008 | NIH | 93.307 | December 2, 2026 | Not listed | Same assistance listing 93.307 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.307 | December 4, 2026 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.394 | January 7, 2027 | $375,000 | Same assistance listing 93.394 as 2 awards here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.394 | January 7, 2027 | $500,000 | Same assistance listing 93.394 as 2 awards here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.394 | January 7, 2027 | $499,999 | Same assistance listing 93.394 as 2 awards here |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) | PAR-25-098 | NIH | 93.307 | January 7, 2027 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.307 | January 7, 2027 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | RFA-CA-27-005 | NIH | 93.394 | January 11, 2027 | $700,000 | Same assistance listing 93.394 as 2 awards here |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | PAR-27-009 | NIH | 93.394 | January 25, 2027 | Not listed | Same assistance listing 93.394 as 2 awards here |
| Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) | RFA-CA-26-010 | NIH | 93.394 | January 25, 2027 | Not listed | Same assistance listing 93.394 as 2 awards here |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | RFA-CA-27-003 | NIH | 93.394 | January 25, 2027 | Not listed | Same assistance listing 93.394 as 2 awards here |
| Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional) | RFA-MD-27-001 | NIH | 93.307 | January 25, 2027 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) | RFA-CA-28-004 | NIH | 93.394 | February 11, 2027 | Not listed | Same assistance listing 93.394 as 2 awards here |
| Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional) | RFA-MD-27-004 | NIH | 93.307 | February 16, 2027 | Not listed | Same assistance listing 93.307 as 2 awards here |
| Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) | PAR-25-317 | NIH | 93.307 | March 6, 2027 | Not listed | Same assistance listing 93.307 as 2 awards here |
Topics of its NIH awards
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.